Second primary malignancies in cancer survivors: epidemiology, role of anticancer therapy
The recent years have seen considerable advancement in the therapy of oncology patients and hence better survival and longer lifespan. Thus, studies on the distant effects of antitumor therapy have become increasingly important. That particularly concerns the risk of development of the second primar...
Saved in:
| Main Author: | L. G. Solenova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2016-09-01
|
| Series: | Успехи молекулярной онкологии |
| Subjects: | |
| Online Access: | https://umo.abvpress.ru/jour/article/view/68 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Second primary malignancies of cancer patients: treatment-related carcinogenesis
by: G. A. Belitskiy, et al.
Published: (2016-09-01) -
Guidance letter for cardiologists and primary care physicians on primary prevention of cardiovascular complications of anticancer therapy. Interdisciplinary Council of Cardio-Oncology, Russian Society of Cardiology
by: Yu. A. Vasyuk, et al.
Published: (2023-09-01) -
Guidance letter for cardiologists of oncology institutions on the prevention of cardiovascular complications of anticancer therapy. Interdisciplinary Council of Cardio-Oncology, Russian Society of Cardiology
by: Yu. A. Vasyuk, et al.
Published: (2023-09-01) -
MODERN ONCO DRUG FOR INTERNAL USE
by: O. L. Orlova, et al.
Published: (2018-11-01) -
Cellular microenvironment as an object of targeted therapy for malignant neoplasms
by: E. Yu. Zyablitskaya, et al.
Published: (2023-12-01)